Provided by Tiger Fintech (Singapore) Pte. Ltd.

Carisma Therapeutics

0.2253
+0.01014.69%
Volume:70.14K
Turnover:15.14K
Market Cap:9.41M
PE:-0.15
High:0.2254
Open:0.2190
Low:0.2081
Close:0.2152
Loading ...
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 10, 2024

Major Issues Report

Form 8-K - Current report
Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 13, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2023

Correspondence

Form CORRESP - Correspondence